A combination of benzoxazole, phenoxyalkyl side chain, and phenoxybutyric acids was identified as a highlypotent and selective human peroxisome proliferator-activated receptor alpha (PPARalpha) agonist. The synthesis, structure-activity relationship (SAR) studies, and in vivo activities of the representative compounds are described.